Spots Global Cancer Trial Database for Open-Label Surufatinib in European Patients With NET
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Open-Label Surufatinib in European Patients With NET
Official Title: An Open-Label Phase 2 Study of Surufatinib in Patients With Neuroendocrine Tumours in Europe
Study ID: NCT04579679
Interventions
Study Description
Brief Summary: This is a Phase 2, open-label, multi-centre study of surufatinib in patients with low to intermediate grade (Grade 1 or Grade 2), well-differentiated neuroendocrine tumours (NETs).
Detailed Description: This is a Phase 2, open-label, multi-centre study of surufatinib in patients with low- to intermediate-grade (Grade 1 or Grade 2), well-differentiated NETs. The study will enroll 4 cohorts of varying NETs, as follows: * Cohort A - NET of lung origin * Cohort B - NET of small bowel origin * Cohort C - NET of non-small bowel, non-pancreas, and non-lung origin * Cohort D - NET of any origin (DDI substudy) All patients will be treated with oral surufatinib 300 mg QD in treatment cycles of 28 days starting on Cycle 1 Day 1.
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
University of Alabama, Birmingham (UAB), Birmingham, Alabama, United States
University of California Irvine Medical Center UCIMC - H.H. Chao Comprehensive Digestive Disease Center CDDC, Orange, California, United States
Emory University, Winship Cancer Institute, Atlanta, Georgia, United States
Stony Brook Cancer Center, Stony Brook, New York, United States
Houston Methodist, Houston, Texas, United States
CHU Bordeaux, Pessac, , France
Institut Gustave Roussy, Villejuif, , France
Charite Universitatsmedizin Berlin, Berlin, , Germany
Universitaetsklinikum Erlangen, Erlangen, , Germany
Universitatsklinikum Essen, Klinik fur Endokrinologie, Essen, , Germany
Azienda Universitaria Ospedaliera Consorziale - Policlinico Bari, Bari, , Italy
ASST-Spedali Civili di Brescia, Brescia, , Italy
Universita degli Studi di Firenze - Azienda Ospedaliero Universitaria Careggi (AOUC), Firenze, , Italy
Istituto Europeo di Oncologia, Milano, , Italy
Haukeland University Hospital, Bergen, , Norway
Oslo University Hospital Rikshospitalet, Oslo, , Norway
Institut Catala d'Oncologis (ICO) - Hospital Duran i Reynals, Barcelona, , Spain
Hospital Vall Hebron, Barcelona, , Spain
Hospital Universitario Ramon y Cajal, Madrid, , Spain
Hospital Universitario 12 de Octubre, Madrid, , Spain
Hospital Universitario Virgen del Rocio, Sevilla, , Spain
Sarah Cannon Research Institute, London, , United Kingdom
Christie Hospital, Manchester, , United Kingdom
Contact Details
Name: John Kauh, MD
Affiliation: Hutchmed
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
